Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The objective of this study was to investigate the bioequivalence of Mylan\'s sumatriptan succinate 100 mg tablets to GSK\'s Imitrex® 100 mg tablets following a single, oral 100 mg (1 x 100 mg) dose administration under fasting conditions.
Epistemonikos ID: c61ca1fb412ca33b28b4bdd380fdc91d9339e1f6
First added on: May 04, 2024